MARIA YBALLE: Open Payments
NPI 1447850490 · NORTH BERGEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$630 in 37 payments from 13 companies in 2025. Trend: 2023 $690 · 2024 $470 · 2025 $630
Food & beverage: $630
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 7 | $123 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $116 |
| ABBVIE INC. | 5 | $88 |
| Xeris Pharmaceuticals, Inc. | 3 | $45 |
| SANOFI-AVENTIS U.S. LLC | 3 | $44 |
| Corcept Therapeutics | 3 | $41 |
| Tandem Diabetes Care, Inc. | 2 | $41 |
| Novo Nordisk Inc | 2 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| Insulet Corporation | 1 | $24 |
Products named: JARDIANCE, SYNTHROID, MOUNJARO, GVOKE HYPOPEN, TZIELD, Korlym, t:slim X2 Insulin Pump with Control-IQ, Kerendia.
Industry payments across NJ — which companies pay providers there.
